- Home
- VYNE vs OKYO Comparison
VYNE vs OKYO Comparison
Compare VYNE & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- OKYO
- Stock Information
- Founded
- VYNE 2003
- OKYO 2007
- Country
- VYNE United States
- OKYO United Kingdom
- Employees
- VYNE N/A
- OKYO N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VYNE Health Care
- OKYO Health Care
- Exchange
- VYNE Nasdaq
- OKYO Nasdaq
- Market Cap
- VYNE 35.7M
- OKYO 37.0M
- IPO Year
- VYNE 2018
- OKYO 2022
- Fundamental
- Price
- VYNE $1.30
- OKYO $1.45
- Analyst Decision
- VYNE Strong Buy
- OKYO Strong Buy
- Analyst Count
- VYNE 2
- OKYO 1
- Target Price
- VYNE $6.25
- OKYO $7.00
- AVG Volume (30 Days)
- VYNE 222.4K
- OKYO 87.6K
- Earning Date
- VYNE 05-08-2025
- OKYO 05-16-2025
- Dividend Yield
- VYNE N/A
- OKYO N/A
- EPS Growth
- VYNE N/A
- OKYO N/A
- EPS
- VYNE N/A
- OKYO N/A
- Revenue
- VYNE $605,000.00
- OKYO N/A
- Revenue This Year
- VYNE N/A
- OKYO N/A
- Revenue Next Year
- VYNE N/A
- OKYO N/A
- P/E Ratio
- VYNE N/A
- OKYO N/A
- Revenue Growth
- VYNE 43.03
- OKYO N/A
- 52 Week Low
- VYNE $1.27
- OKYO $0.81
- 52 Week High
- VYNE $4.30
- OKYO $1.74
- Technical
- Relative Strength Index (RSI)
- VYNE 34.90
- OKYO 54.76
- Support Level
- VYNE $1.27
- OKYO $1.43
- Resistance Level
- VYNE $1.41
- OKYO $1.65
- Average True Range (ATR)
- VYNE 0.12
- OKYO 0.14
- MACD
- VYNE -0.01
- OKYO -0.00
- Stochastic Oscillator
- VYNE 5.46
- OKYO 54.39
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.